Your browser doesn't support javascript.
loading
Distinct Neoadjuvant Chemotherapy Response and 5-Year Outcome in Patients With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Tumors That Reclassify as Basal-Type by the 80-Gene Signature.
Whitworth, Pat W; Beitsch, Peter D; Pellicane, James V; Baron, Paul L; Lee, Laura A; Dul, Carrie L; Murray, Mary K; Gittleman, Mark A; Budway, Raye J; Rahman, Rakhshanda Layeequr; Kelemen, Pond R; Dooley, William C; Rock, David T; Cowan, Kenneth H; Lesnikoski, Beth-Ann; Barone, Julie L; Ashikari, Andrew Y; Dupree, Beth B; Wang, Shiyu; Menicucci, Andrea R; Yoder, Erin B; Finn, Christine; Corcoran, Kate; Blumencranz, Lisa E; Audeh, William.
Afiliación
  • Whitworth PW; Nashville Breast Center, Nashville, TN.
  • Beitsch PD; Targeted Medical Education, Cupertino, CA.
  • Pellicane JV; Targeted Medical Education, Cupertino, CA.
  • Baron PL; Dallas Surgical Group, Dallas, TX.
  • Lee LA; Bon Secours Cancer Institute, Richmond, VA.
  • Dul CL; Breast and Melanoma Specialist of Charleston, Charleston, SC.
  • Murray MK; Lenox Hill Hospital/Northwell Health, New York, NY.
  • Gittleman MA; Comprehensive Cancer Center, Palm Springs, CA.
  • Budway RJ; Ascension St John Hospital Great Lakes Cancer Management Specialists, Grosse Pointe Woods, MI.
  • Rahman RL; Akron General Medical Center, Akron, OH.
  • Kelemen PR; Cleveland Clinic Akron General, Akron, OH.
  • Dooley WC; Breast Care Specialists, Allentown, PA.
  • Rock DT; St Clair Hospital, Pittsburgh, PA.
  • Cowan KH; Texas Tech University, Lubbock, TX.
  • Lesnikoski BA; Ashikari Breast Center, Sleepy Hollow, NY.
  • Barone JL; Zucker School of Medicine, Hofstra University, Hempstead, NY.
  • Ashikari AY; Breast Institute, University of Oklahoma Health Sciences, Oklahoma City, OK.
  • Dupree BB; Stephenson Cancer Center, Oklahoma City, OK.
  • Wang S; Regional Breast Care, Fort Myers, FL.
  • Menicucci AR; Genesis Care, Fort Myers, FL.
  • Yoder EB; Fred and Pamela Buffet Cancer Center and Eppley Institute for Research in Cancer at University of Nebraska Medical Center, Omaha, NE.
  • Finn C; The Breast Institute at JFK Medical Center, Atlantis, FL.
  • Corcoran K; Baptist MD Anderson Cancer Center, Jacksonville, FL.
  • Blumencranz LE; Exempla Saint Joseph Hospital, Denver, CO.
  • Audeh W; Vail Health, Vail, CO.
JCO Precis Oncol ; 6: e2100463, 2022 04.
Article en En | MEDLINE | ID: mdl-35476550
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Terapia Neoadyuvante / Neoplasias de la Mama Triple Negativas Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Revista: JCO Precis Oncol Año: 2022 Tipo del documento: Article País de afiliación: Túnez
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Terapia Neoadyuvante / Neoplasias de la Mama Triple Negativas Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Revista: JCO Precis Oncol Año: 2022 Tipo del documento: Article País de afiliación: Túnez